Delivery Order SPE2DB20D3103-SPE2DB26FL4K2
- Not listed
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $21,775.72 to AmerisourceBergen Drug Corp for the supply of Adacel TDAP syringes (0.5mL) with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, regularly supplies...
- The Defense Logistics Agency awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5ML) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a routine pharmaceutical procurement through the federal medical supply chain, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $33.5K delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) under a firm fixed-price contract with a completion date of September 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical and medical supply vendor for federal healthcare procurement. The order was placed to the company's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered...
- The Defense Logistics Agency awarded a $1,670.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded on July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that maintains an extensive portfolio of products...
- The Defense Logistics Agency awarded a $18,973.02 delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringe 0.5ML under a firm fixed-price contract type with an ultimate completion date of August 13, 2025. This non-set-aside award is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adacel TDAP syringes (0.5mL) valued at $1,072.00. The contract employs firm fixed price pricing with a completion date of August 26, 2025, and is classified as a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a $4,690.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5ML) with a completion date of September 3, 2025. The contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $15,084.90 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on May 14, 2025, with completion scheduled for May 15, 2025. This non-set-aside contract employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under AmerisourceBergen's existing federal contract framework with the Defense Logistics...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4K2Delivery Order
The Defense Logistics Agency awarded a $20,435.72 delivery order to AmerisourceBergen Drug Corp for 0.5ML Adacel TDAP syringes under a firm fixed price contract structure. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small transaction within the company's broader federal pharmaceutical supply portfolio. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, syringes, and other medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills DLA requirements through competitively awarded contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 10/30/25 |